The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
63 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $119,776,069 in first-year total cost, median $834,068.
Most frequent study sections
- Special Emphasis Panel[ZRG1 MDCN-E (56)]25
- Special Emphasis Panel[ZRG1 MDCN-T (56)]19
- Special Emphasis Panel[ZRG1-MDCN-E(56)R]10
- Special Emphasis Panel[ZRG1 MDCN-A (56)]2
- Macromolecular Structure and Function C Study Section[MSFC]1
Most frequent institutions
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI5
- UNIVERSITY OF CALIFORNIA-IRVINE5
- JACKSON LABORATORY3
- UNIVERSITY OF PENNSYLVANIA3
- UNIVERSITY OF SOUTH FLORIDA3
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | Systems Genetic Analysis of Cognitive Resilience Using Multi-Parent Crosses1RF1AG063755-01 | KACZOROWSKI, CATHERINE COOK | JACKSON LABORATORY, ME | $5,201,511 | ZRG1 |
| 2019 | Proteomic and Genetic Approaches Defining Apolipoprotein E4 Neuropathologic Mechanisms1RF1AG059751-01A1 | KROGAN, NEVAN JMAHLEY, ROBERT W. | J. DAVID GLADSTONE INSTITUTES, CA | $4,669,193 | ZRG1 |
| 2019 | Integrated understanding of complex viral network biology in Alzheimer's Disease1RF1AG058469-01A1 | EHRLICH, MICHELLE EGANDY, SAMUEL E. | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $4,111,077 | ZRG1 |
| 2019 | Systems-level functional proteomics analysis assemblies in Alzheimer's disease and mouse models of tauopathy1RF1AG061706-01 | EMILI, ANDREWWOLOZIN, BENJAMIN L | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $3,945,190 | ZRG1 |
| 2019 | Connexin 43 and hemorrhagic complication in cerebral amyloid angiopathy1RF1AG064957-01 | ANDJELKOVIC-ZOCHOWSKA, ANUSKA V. | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $2,251,499 | ZRG1 |
| 2019 | Mechanisms of APOE-Induced Preclinical Alzheimer's Pathophysiology in Human Olfactory System1R01AG063881-01 | MISIAK, MAGDALENA MARIANWULIA, EVARISTUS AOBISESAN, THOMAS O | HOWARD UNIVERSITY, DC | $770,120 | ZRG1 |
| 2019 | Complexity and Heterogeneity of Alzheimer disease1R56AG061196-01 | HYMAN, BRADLEY T. | MASSACHUSETTS GENERAL HOSPITAL, MA | $653,558 | ZRG1 |
| 2019 | Uncovering the molecular and cellular mechanisms underlying AD using CRISPR/Cas9-edited isogenic neural cells1R56AG061171-01 | SHI, YANHONG | BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA | $628,647 | ZRG1 |
| 2019 | Vacuolar Tauopathy1R56AG063344-01 | LEE, EDWARD BYUNG-HA | UNIVERSITY OF PENNSYLVANIA, PA | $624,837 | ZRG1 |
| 2019 | Modulation of Alzheimers disease by Herpes simplex virus infection1R01AG062514-01 | DARVAS, MARTIN CFUNK, CORYJOHNSTON, CHRISTINE MICHELLE | UNIVERSITY OF WASHINGTON, WA | $618,734 | ZRG1 |
| 2019 | Conformational and functional analysis of Apolipoprotein E1R01AG062837-01 | SORANNO, ANDREA | WASHINGTON UNIVERSITY, MO | $452,416 | MSFC |
| 2019 | Epigenetic roles of DNA adenine methylation in Alzheimer's Disease1R01AG062577-01 | YAO, BING | EMORY UNIVERSITY, GA | $395,513 | ZRG1 |
| 2019 | Differential vulnerability to tauopathy in Alzheimer's disease and Frontotemporal Lobe Dementia1RF1AG063521-01 | DUFF, KAREN | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $390,972 | ZRG1 |
| 2019 | Peripheral Immune mechanisms involved in the etiology of Alzheimer's disease1R56AG064709-01 | AGRAWAL, ANSHU | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $384,800 | ZRG1 |
| 2018 | Functional Networks in Microglia and Astrocytes Regulating Neuropathology of Alzheimer's Disease1RF1AG059770-01 | MILOSEVIC, ANA | ROCKEFELLER UNIVERSITY, NY | $4,144,506 | ZRG1 |
| 2018 | Systems Genetics Approach to Determine Interactors of Apolipoprotein E in Alzheimer’s Disease1RF1AG055104-01A1 | CARTER, GREGORY WHOWELL, GARETH RSASNER, MICHAEL | JACKSON LABORATORY, ME | $4,075,379 | ZRG1 |
| 2018 | Capturing the molecular complexity of Alzheimer's disease through the lens of RNA binding proteins1RF1AG056318-01A1 | LI, HUWOLOZIN, BENJAMIN L | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $3,944,412 | ZRG1 |
| 2018 | Gene x Environment Interactions in Hypothalamic Dysfunction in Alzheimer's Disease1RF1AG059778-01 | KACZOROWSKI, CATHERINE COOKO'CONNELL, KRISTEN M | JACKSON LABORATORY, ME | $3,833,547 | ZRG1 |
| 2018 | Epigenetic suppression of histone methylation reverses age and AD-related cognitive decline1RF1AG057558-01A1 | WOOD, MARCELO ANDRES | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $3,774,324 | ZRG1 |
| 2018 | Conformational polymorphisms of amyloid in AD and immunological biomarkers and therapeutics1RF1AG056507-01A1 | GLABE, CHARLES G. | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $3,245,609 | ZRG1 |
| 2018 | The Enhancer Code of AD-A Genetic Approach1R01AG056511-01A1 | GLASS, CHRISTOPHER KROSENFELD, MICHAEL G | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $1,073,248 | ZRG1 |
| 2018 | Computational Prediction and Functional Validation of Novel Risk Loci of Alzheimer's Disease1R56AG060757-01 | JIN, PENGQIN, ZHAOHUIWINGO, THOMAS SPURGEON | EMORY UNIVERSITY, GA | $788,200 | ZRG1 |
| 2018 | The surprising impact of APOE alleles on gut microbiome: does altering the microbiome reduce AD risk?1R56AG057589-01A1 | ESTUS, STEVEN | UNIVERSITY OF KENTUCKY, KY | $610,216 | ZRG1 |
| 2018 | Probing Heterogeneity of Alzheimer's disease using iPSCs1R01AG055909-01A1 | YOUNG-PEARSE, TRACY L | BRIGHAM AND WOMEN'S HOSPITAL, MA | $416,553 | ZRG1 |
| 2018 | Cellular and synaptic signaling mechanisms driving early AD pathology1R56AG055497-01A1 | STUTZMANN, GRACE E. | ROSALIND FRANKLIN UNIV OF MEDICINE & SCI, IL | $390,000 | ZRG1 |
| 2018 | The Role of NgR Mediated Inhibition of New Synapse Assembly in Amyloid Beta Peptide Dependent Learning Deficits1R56AG058593-01 | WILLS, ZACHARY P | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $382,770 | ZRG1 |
| 2018 | CSVD and AD: the drivers of late life dementia1R01AG057665-01A1 | MCLAURIN, JOANNESTEFANOVIC, BOJANA | SUNNYBROOK RESEARCH INSTITUTE, ON | $250,059 | ZRG1 |
| 2017 | Molecular pathobiology of soluble TREM2 in Alzheimer's disease.1RF1AG056130-01 | BU, GUOJUNHUANG, TIMOTHY YIKAI | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA | $4,147,115 | ZRG1 |
| 2017 | Tauopathy in AD and FTD - Molecular Determinants of Phenotypic Diversity1RF1AG056151-01A1 | CARLSON, GEORGE A.DUFF, KARENFINKBEINER, STEVEN M | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $4,102,378 | ZRG1 |
| 2017 | Characterization of Rapidly Progressive Alzheimer's Disease1RF1AG058267-01 | HAINES, JONATHAN LSAFAR, JIRI G.WISNIEWSKI, THOMAS M | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $3,954,153 | ZRG1 |
| 2017 | MSUT2 modulates pathological tau in AD and model organisms1RF1AG055474-01 | KRAEMER, BRIAN C. | SEATTLE INST FOR BIOMEDICAL/CLINICAL RES, WA | $3,173,979 | ZRG1 |
| 2017 | Integrated target discovery in Alzheimer's disease1RF1AG055477-01 | BROWN, CHRISTOPHER DAVID | UNIVERSITY OF PENNSYLVANIA, PA | $2,945,840 | ZRG1 |
| 2017 | Generation of Human iPSC-derived Entorhinal Cortex Neurons for Probing Selective Neuronal Vulnerability in Alzheimer's Disease1RF1AG054564-01 | ROUSSARIE, JEAN-PIERRE | ROCKEFELLER UNIVERSITY, NY | $2,853,240 | ZRG1 |
| 2017 | Innate Immune IL-10/STAT3 Signaling in Alzheimer's Disease1RF1AG053982-01A1 | CHANG, KAREN TCHEN, JEANNIE | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $2,792,837 | ZRG1 |
| 2017 | Examining the role of adaptive immunity in Alzheimer's Disease pathogenesis1RF1AG055524-01A1 | BLURTON-JONES, MATHEW MARK | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $2,708,461 | ZRG1 |
| 2017 | Structure and Genesis of tau Aggregates1RF1AG054018-01A1 | KURET, JEFF | OHIO STATE UNIVERSITY, OH | $2,363,370 | ZRG1 |
| 2017 | Controlling tau toxicity from inside and outside of neurons1RF1AG055088-01 | BICKFORD, PAULA CBLAIR, LAURA JUVERSKY, VLADIMIR N | UNIVERSITY OF SOUTH FLORIDA, FL | $2,315,030 | ZRG1 |
| 2017 | Investigation of the effect of structural modifications of tau on assembly state and seeding1RF1AG054000-01A1 | BITAN, GAL | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $1,947,083 | ZRG1 |
| 2017 | Integrated understanding of complex viral network biology in Alzheimer's Disease1R56AG058469-01 | DUDLEY, JOEL THOMASEHRLICH, MICHELLE EGANDY, SAMUEL E. | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $844,112 | ZRG1 |
| 2017 | Mechanisms of Resilience to Alzheimer's Disease Neuropathology1R56AG058281-01 | MICCI, MARIA-ADELAIDETAGLIALATELA, GIULIO | UNIVERSITY OF TEXAS MED BR GALVESTON, TX | $725,531 | ZRG1 |
| 2017 | Conformational polymorphisms of amyloid in AD and immunological biomarkers and therapeutics1R56AG056507-01 | GLABE, CHARLES G. | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $698,846 | ZRG1 |
| 2017 | S-Nitrosylation-Induced Posttranslational Modification and Aberrant Cell Signaling in Sporadic Alzheimer's Disease1R01AG056259-01 | LIPTON, STUART A | SCRIPPS RESEARCH INSTITUTE, THE, CA | $677,219 | ZRG1 |
| 2017 | Probing the molecular and cellular complexity of APP trafficking and its relationship to AD.1R56AG054013-01A1 | GOLDSTEIN, LAWRENCE S. | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $582,310 | ZRG1 |
| 2017 | Emerging Roles of Higher-order Polyamines During Tauopathies1R01AG054559-01 | LEE, DANIEL CARL | UNIVERSITY OF SOUTH FLORIDA, FL | $540,201 | ZRG1 |
| 2017 | Role of beta-adrenergic receptors in modulation of cognition and central and peripheral immune systems in Alzheimer's disease1R01AG054533-01A1 | SHAMLOO, MEHRDAD | STANFORD UNIVERSITY, CA | $511,011 | ZRG1 |
| 2017 | Defining roles of genetic and age in extracellular elimination of neurotoxic aggregates1R37AG056510-01 | DRISCOLL, MONICA A. | RUTGERS, THE STATE UNIV OF N.J., NJ | $458,880 | ZRG1 |
| 2017 | Impact of Amyloid Beta on Hippocampal Neurophysiology and Calcium Activity across the Sleep-Wake Cycle1R01AG054551-01A1 | GOMPERTS, STEPHEN N. | MASSACHUSETTS GENERAL HOSPITAL, MA | $416,261 | ZRG1 |
| 2017 | Immunotherapy in Alzheimer's Disease Animal Models Using Tau Recombinant Antibodies1R56AG055479-01 | D'ABRAMO, CRISTINA | FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH, NY | $412,500 | ZRG1 |
| 2017 | ROLE OF GLIAL CIRCADIAN CLOCK DYSFUNCTION IN THE PATHOGENESIS OF ALZHEIMER'S DISEASE1R01AG054517-01A1 | MUSIEK, ERIK STEVEN | WASHINGTON UNIVERSITY, MO | $381,250 | ZRG1 |
| 2016 | Understanding the mechanism of SPl1 dependent Alzheimer disease risk1RF1AG054011-01 | GOATE, ALISON M | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $4,223,847 | ZRG1 |
| 2016 | Molecular Characterization and Validation of Gender Differences in Alzheimers Disease Pathogenesis1RF1AG054014-01 | CAI, DONGMINGZHANG, BIN | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $4,211,117 | ZRG1 |
| 2016 | Cell type specific epigenetic analysis to understand complex mechanisms underlying Alzheimer's disease phenotypes1RF1AG054012-01 | KELLIS, MANOLISTSAI, LI-HUEI | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA | $3,861,008 | ZRG1 |
| 2016 | Structure and Inhibition of Amyloid in Alzheimer's Disease1RF1AG054022-01 | EISENBERG, DAVID | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $3,779,925 | ZRG1 |
| 2016 | Contribution of DNA Repair Deficits to Alzheimer Pathogenesis1RF1AG053981-01 | MUCKE, LENNART | J. DAVID GLADSTONE INSTITUTES, CA | $3,714,865 | ZRG1 |
| 2016 | Molecular mechanisms and cellular implications of tau dysfunction1RF1AG053951-01 | ODDE, DAVID J.RHOADES, ELIZABETH | UNIVERSITY OF PENNSYLVANIA, PA | $2,739,985 | ZRG1 |
| 2016 | Cell autonomous and non-cell autonomous roles of the GWAS risk factor BIN1 in Alzheimer's disease neuropathology1RF1AG054223-01 | THINAKARAN, GOPAL | UNIVERSITY OF CHICAGO, IL | $2,060,594 | ZRG1 |
| 2016 | Regulation of tau expression in Alzheimer disease and aging1R01AG054008-01 | CRARY, JOHN FONDA | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $834,068 | ZRG1 |
| 2016 | Tau-Spliceosome Interactions in Alzheimer's Disease1R01AG053960-01 | SEYFRIED, NICHOLAS THOMASSHULMAN, JOSHUA M | BAYLOR COLLEGE OF MEDICINE, TX | $648,994 | ZRG1 |
| 2016 | A multi-scale data-driven model of the Abeta pore function and Ca2+ toxicity in Alzheimer's disease1R01AG053988-01 | DEMURO, ANGELOULLAH, GHANIM | UNIVERSITY OF SOUTH FLORIDA, FL | $465,335 | ZRG1 |
| 2016 | Multi-level Integrative Proteomics to Alzheimer's Disease Pathways1R01AG053987-01 | PENG, JUNMIN | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, TN | $459,835 | ZRG1 |
| 2016 | Mechanisms of Apolipoprotein E Isoform Conferred Susceptibility and Resistance to Alzheimer's Disease1R01AG053990-01 | SADOWSKI, MARTIN JOSEPH | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $435,679 | ZRG1 |
| 2016 | Formation and Propagation of Tau Oligomeric Strains in Alzheimer's Disease1R01AG054025-01 | KAYED, RAKEZ | UNIVERSITY OF TEXAS MED BR GALVESTON, TX | $387,500 | ZRG1 |
| 2016 | Role of Systemic Amylin Dyshomeostasis in Alzheimer's Disease1R01AG053999-01 | DESPA, FLORIN | UNIVERSITY OF KENTUCKY, KY | $374,820 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.